iFabric Corp. J (TSE:IFA)
TSX:IFA
Want to see TSE:IFA full AI Analyst Report?
Top Page
iFabric
(TSX:IFA)
Select Model
Select Model
Rating:59Neutral
Price Target:
C$4.50
▲(140.64% Upside)
Action:ReiteratedDate:04/10/26
The score is held back primarily by weak cash generation and deteriorated profitability alongside rising leverage, despite strong reported revenue momentum. Technicals are a clear positive with an ongoing uptrend, and the earnings call supports a growth-and-margin-recovery narrative, but execution and working-capital risks keep the overall rating moderate.
Positive Factors
Retail rollouts & recurring cadence
Large, structural retailer distribution (Walmart ~1,367 stores) plus a 52‑week replenishment model creates predictable, recurring demand. This supports durable revenue visibility, smoother reorder cycles, and scale benefits for production and procurement over the next 2–6 months and beyond.
Negative Factors
Negative cash generation
Persistent cash burn reduces financial flexibility and increases reliance on external financing. With working capital tied up (inventory build) and negative operating cash flow, the company faces execution risk if sales convert slower than expected or credit terms tighten.
Read all positive and negative factors
Positive Factors
Negative Factors
Retail rollouts & recurring cadence
Large, structural retailer distribution (Walmart ~1,367 stores) plus a 52‑week replenishment model creates predictable, recurring demand. This supports durable revenue visibility, smoother reorder cycles, and scale benefits for production and procurement over the next 2–6 months and beyond.
Read all positive factors
iFabric (IFA) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$133.92M
Dividend YieldN/A
Average Volume (3M)9.50K
Price to Earnings (P/E)―
Beta (1Y)-0.92
Revenue Growth20.30%
EPS Growth-106.12%
CountryCA
Employees36
SectorConsumer Cyclical
Sector Strength84
IndustryApparel - Manufacturers
Share Statistics
EPS (TTM)-0.02
Shares Outstanding30,299,467
10 Day Avg. Volume14,356
30 Day Avg. Volume9,500
Financial Highlights & Ratios
PEG Ratio-6.05
Price to Book (P/B)1.82
Price to Sales (P/S)1.20
P/FCF Ratio-7.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$4.50Price Target Upside140.64% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.09
Revenue Forecast (FY)C$61.60M
iFabric Business Overview & Revenue Model
Company Description
iFabric Corp. designs and distributes women's intimate apparel and accessories in Canada, the United States, the United Kingdom, Southeast Asia, and internationally. The company's Intimate Apparel division engages in the design, purchase, and dist...
How the Company Makes Money
iFabric makes money primarily by commercializing its textile treatment technology and related finished or treated textile products. Key revenue streams include: (1) selling and/or supplying PROTECTiT-treated fabrics and finished textile goods to c...
iFabric Earnings Call Summary
Earnings Call Date:Mar 31, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:May 20, 2026
Earnings Call Sentiment Positive
Overall the call presents a positive growth narrative: management reported record revenue in 2025, provided very strong Q1 2026 guidance ($25M–$27M) driven by large retailer rollouts (notably Walmart expansion), launched its own higher‑margin intimate apparel brand (eliminating royalties), and received tariff clarity plus a material potential refund. These positives are tempered by notable near‑term challenges — compressed gross margins in 2025, an adjusted EBITDA decline, a significant inventory build funded by the credit line, timing/recognition noise from late shipments, pending refund timing, and ongoing supply chain/geopolitical risks. Management expects margins and EBITDA to improve as one‑time costs recede, royalties are eliminated and tariffs are largely resolved. On balance the highlights (growth runway, retail expansion, proprietary clinical data and margin levers) outweigh the lowlights, though execution and working capital management remain critical in the near term.Positive Updates
Record Revenue Growth (Fiscal 2025)
Fiscal 2025 revenue $32.9M vs $27.3M prior year (+20% YoY). Q4 2025 was a record $11.0M (vs $10.5M, +5% YoY). Management attributes strong top-line momentum to multiple retail programs and product launches.
Negative Updates
Gross Margin Compression
Fiscal gross margin declined from 41% to 32% YoY; Q4 margin fell from 40% (2024) to 26% (2025). Management attributes the decline primarily to tariffs, the temporary halt of intimate apparel shipments in Q4 and strategic promotional spend to secure shelf position.
Read all updates
Q4-2025 Updates
Positive
Negative
Record Revenue Growth (Fiscal 2025)
Fiscal 2025 revenue $32.9M vs $27.3M prior year (+20% YoY). Q4 2025 was a record $11.0M (vs $10.5M, +5% YoY). Management attributes strong top-line momentum to multiple retail programs and product launches.
Read all positive updates
Company Guidance
Management guided Q1 2026 revenue of $25–$27 million, noting about $1 million of product shipped in late December that was deferred into Q1 by Costco’s receipt rule, partial recognition of an $8 million Roots order (split between Q4 and Q1), expansion of the scrubs program from an initial ~367 stores to ~1,367 stores (~20% of ~4,400 US Walmarts), new intimate-apparel launches and expanded Walmart SKU sets; scrubs are sold on a 52‑week replenishment cadence. For context they reported FY2025 revenue of $32.9M (+20% vs $27.3M in 2024), Q4 revenue of $11M (+5%), adjusted EBITDA of $1.9M (vs $2.7M), FY gross margin down to ~32% (Q4 ~26% vs ~40% prior year), inventories up to $21M from $10.1M, cash $3.8M (from $2.1M) with $6.7M drawn on the credit line, a USD $600k (~CAD $800k) tariff refund claim, one‑time ERP costs (~$200k in 2025; ~ $0.5M total investment), and targets to reach ~15% adjusted EBITDA margin in 2026 and ~20% in 2027 driven by resumption of higher‑margin intimates (mid‑40s–low‑50s GP), IFTNA mix (35–40% GP), lower royalties and the new 10% tariff vs prior higher duties.iFabric Financial Statement Overview
Summary
Income Statement
52
Neutral
Balance Sheet
63
Positive
Cash Flow
32
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 32.87M | 32.39M | 27.33M | 22.72M | 19.74M | 19.76M |
| Gross Profit | 10.44M | 11.71M | 11.27M | 8.84M | 7.03M | 7.76M |
| EBITDA | 751.51K | 2.39M | 2.11M | -2.26M | -27.09K | 3.21M |
| Net Income | -99.19K | 1.57M | 1.63M | -1.69M | -452.46K | 2.37M |
Balance Sheet | ||||||
| Total Assets | 42.99M | 30.56M | 29.49M | 25.91M | 27.37M | 27.63M |
| Cash, Cash Equivalents and Short-Term Investments | 3.78M | 1.23M | 2.06M | 1.57M | 944.73K | 8.90M |
| Total Debt | 10.90M | 6.40M | 1.88M | 2.03M | 1.24M | 1.27M |
| Total Liabilities | 22.29M | 9.26M | 6.35M | 5.21M | 4.60M | 5.35M |
| Stockholders Equity | 20.70M | 21.30M | 23.13M | 20.69M | 22.75M | 22.27M |
Cash Flow | ||||||
| Free Cash Flow | -4.74M | -5.40M | 208.92K | 644.99K | -8.45M | -2.48M |
| Operating Cash Flow | -4.40M | -5.16M | 301.78K | 833.77K | -8.21M | -2.22M |
| Investing Cash Flow | -337.06K | -247.06K | -52.86K | -138.38K | -242.76K | -253.40K |
| Financing Cash Flow | 6.78M | 2.35M | -214.74K | -14.42K | 41.93K | 10.46M |
iFabric Technical Analysis
Positive
1.87
Price Trends
2.69
Positive
2.18
Positive
1.64
Positive
Market Momentum
0.35
Negative
71.50
Negative
92.52
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:IFA, the sentiment is Positive. The current price of 1.87 is below the 20-day moving average (MA) of 3.46, below the 50-day MA of 2.69, and above the 200-day MA of 1.64, indicating a bullish trend. The MACD of 0.35 indicates Negative momentum. The RSI at 71.50 is Negative, neither overbought nor oversold. The STOCH value of 92.52 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:IFA.
iFabric Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | C$150.58M | 25.19 | 3.16% | ― | 5.61% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | C$133.92M | -25.75 | -0.47% | ― | 20.30% | -106.12% | |
58 Neutral | C$1.55B | 3.20 | 4.23% | ― | 10.15% | -70.64% | |
57 Neutral | C$48.24M | 37.18 | -8.97% | ― | 10.84% | ― | |
55 Neutral | C$41.83M | 9.24 | 12.40% | ― | -4.74% | ― | |
54 Neutral | C$103.34M | -121.63 | -0.06% | ― | 0.40% | -108.80% |
* Consumer Cyclical Sector Average
TSE:IFA
iFabric
4.37
3.39
345.92%
TSE:RET
Reitmans (Canada)
2.15
-0.05
-2.27%
TSE:UNI
Unisync
2.18
1.00
84.75%
TSE:GOOS
Canada Goose Holdings
15.93
4.43
38.52%
TSE:ROOT
Roots Corporation
3.86
1.40
56.59%
TSE:MENE
Mene
0.19
0.05
40.74%
iFabric Corporate Events
Business Operations and StrategyFinancial Disclosures
iFabric Posts Record 2025 Revenue and Lifts Q1 2026 Outlook Amid Brand Shift
Positive
Mar 31, 2026
iFabric Corp. reported record full-year 2025 revenue of $32.9 million, up 20% from 2024, driven by a 33% increase in its Intelligent Fabrics division to $26.2 million on the back of category expansion and strong growth in medical apparel programs....
Business Operations and StrategyFinancial Disclosures
iFabric Projects Record 2025 Revenue and Transformative Growth in 2026
Positive
Mar 16, 2026
iFabric Corp. estimates fiscal 2025 revenue at about $33 million, a 20% year-over-year increase and a new annual record, while projecting first-quarter 2026 revenue between $20 million and $25 million, which would mark the largest quarter in its h...
Business Operations and StrategyProduct-Related Announcements
iFabric’s Doctor’s Choice Medical Scrubs Win 1,000-Store U.S. Retail Expansion
Positive
Mar 4, 2026
iFabric Corp.’s subsidiary Intelligent Fabric Technologies (North America) has secured a 1,000-store expansion for its Doctor’s Choice scrubs at a major U.S. national big-box retailer, following an initial rollout that moved from onlin...
Business Operations and StrategyProduct-Related Announcements
iFabric launches clinically validated Frontline antimicrobial scrubs at major Canadian wholesale club
Positive
Feb 18, 2026
iFabric’s subsidiary Intelligent Fabric Technologies (North America) has launched Frontline, a new line of medical scrubs at a major Canadian wholesale club, embedding its PROTX2 antimicrobial and ecoPEL water-repellent technologies. The mov...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.